GLP-2 TRZ Peptides 60mg

Advance your protocol with a precisely prepared GLP-2 analog engineered for consistency, reliability, and disciplined laboratory work.

This GLP-2 TRZ lyophilized peptide vial is produced for controlled research applications and supplied as a stable, off-white powder for streamlined handling. It is a non-flavored, non-consumable laboratory format designed to support reproducible outcomes, with a total content of 60mg per vial. Manufactured and filled in the USA, each lot is processed to exacting specifications to help protect peptide integrity from synthesis through final packaging.

  • Each vial contains 60mg of GLP-2 TRZ, a glucagon-like peptide-2 analog commonly investigated for receptor signaling, intestinal mucosal biology, and related mechanistic studies.

As a lyophilized research material, GLP-2 TRZ is suited to standard reconstitution workflows using appropriate sterile diluents validated by your laboratory. The material’s uniform composition and tight specifications are intended to support assay repeatability across receptor-binding evaluations, cell-based experiments, and other in vitro or ex vivo investigative models. Researchers value this format for its handling efficiency, measured presentation, and dependable performance from vial to vial.

Expect clean, unadulterated presentation with no added flavors or excipients. Physical characteristics are optimized for ease of reconstitution and careful aliquoting under typical laboratory controls. The precise fill and labeled total content facilitate method development, documentation, and ongoing quality records within regulated or quality-conscious environments.

Ingredients: GLP-2 TRZ.

Quality and compliance you can trust: Peptide Scientific Labs prioritizes purity and traceability at every stage. Lots are identity-verified and purity-assessed using industry-standard instrumentation, with documentation available to support your internal QA needs. Handling and filling are performed under controlled, aseptic conditions, and each product is released with clear labeling to maintain chain-of-custody and method transparency. Manufactured in the USA. For laboratory research use only. Not for human or animal consumption. Not for diagnostic, therapeutic, or clinical use.

Total Strength
60mg
Strength Per vial
60mg/vial
Total Units
1 vial
Weight
0.70oz

We prioritize your satisfaction above all, which is why we offer a 100-day, no-questions-asked guarantee on all our products. Learn more about our return policy.

  • Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
  • Shipping is free on orders of $99+ (except Hawaii and Alaska).
  • All orders ship in discreet packaging via USPS Ground Advantage mail.

Delivery restrictions vary by state.

Customer Reviews

There are no reviews yet. Be the first to write a review!

Frequently Asked Questions

What is GLP-2 TRZ?

GLP-2 TRZ appears to be a supplier-specific name for a GLP-2-oriented research compound or analog. Because the 'TRZ' suffix is not a universal scientific naming standard, the exact structure should be confirmed from the product specification or COA. Conservative site copy should therefore describe it as a GLP-2-pathway laboratory compound.

What is GLP-2 TRZ typically studied for?

GLP-2-related compounds are usually studied for intestinal growth, mucosal integrity, nutrient-absorption physiology, and gut-repair signaling. The safest FAQ wording is to explain those GLP-2 research themes while noting that the exact behavior of this product depends on the specific analog being sold.

What are GLP peptides?

GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.

A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.

How do GLP analogs differ from native GLP hormones?

Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.

This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.

What is the difference between GLP-1, GLP-2, and GLP-3 in research?

GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.

GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.

Recently Viewed